Skip to Content Facebook Feature Image

STAGWELL (STGW) REVEALS NEW SINGAPORE HUB TO POWER AI-DRIVEN GROWTH AND INNOVATION ACROSS APAC

Business

STAGWELL (STGW) REVEALS NEW SINGAPORE HUB TO POWER AI-DRIVEN GROWTH AND INNOVATION ACROSS APAC
Business

Business

STAGWELL (STGW) REVEALS NEW SINGAPORE HUB TO POWER AI-DRIVEN GROWTH AND INNOVATION ACROSS APAC

2025-11-24 13:30 Last Updated At:15:14

New hub, located at Solaris @ one north, brings together Stagwell's agencies across creativity, media, and advanced AI solutions to accelerate client success

SINGAPORE, Nov. 24, 2025 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challenger network built to transform marketing, today announces its new APAC headquarters situated in Singapore's Solaris, a Green Mark Platinum-certified campus in the city's one north innovation precinct.

Opening in Q1 2026, the new hub offers a modern, sustainable environment that underscores Stagwell's vision for responsible growth, and its ambition within Singapore's innovation economy. The campus will feature flexible layouts, tech-enabled collaboration zones, and community spaces designed to foster creativity and hybrid work. It unites Stagwell's Singapore agencies – including ADK, Allison, Assembly, Forsman & Bodenfors, HarrisX, Ink Global, and Locaria – alongside other leading brands in the network, creating a single space for collaboration, growth, and AI-powered innovation.

By bringing together creative, communications, digital transformation, brand experience, media and advanced AI capabilities under one roof, Stagwell will:

  • Accelerate solution-building with integrated teams working side by side.
  • Enable real-time collaboration across disciplines for faster decision-making.
  • Enhance operational agility to deliver faster, smarter and more predictive marketing strategies for evolving client needs.

"Singapore is the engine of our growth in Asia. The new Stagwell Singapore campus brings creativity, media, communications, data, and AI together so we can move faster for clients," said Randy Duax, Managing Director, Stagwell Asia-Pacific. "This is the new model. More connected, more inventive, and built for the momentum of local markets. Asia is where the future of this industry is being built, and Stagwell is building it."

"Our new home at Solaris @ one north reflects Stagwell's commitment to building for the future," added Connie Chan, Chief Growth Officer, Stagwell APAC. "It's a space designed for collaboration, creativity, and sustainability – so we can show up stronger for clients in Singapore and across APAC."

Bart Price, CEO of Vita Partners, Owner and Manager of Solaris @ one north – said, "We are excited to welcome Stagwell to Solaris @ one north and have their Asia Pacific headquarters in our building. Stagwell's presence in the building strengthens our vision of creating vibrant ecosystems for innovative and forward-thinking occupiers across the Asia Pacific region."

This announcement comes after an exciting year of momentum for Stagwell in APAC following the acquisition of ADK GLOBAL earlier this year, the expansion of the Future of News initiative to Singapore in October and the launch of Stagwell Media Platform, a centralised team of global media, technology, and data investment experts. 

Most recently, Stagwell announced a new partnership with Palantir centered around building a groundbreaking, industry-first AI and data platform that offers clients a fast path to a central source of marketing and advertising targeting information that unlocks new ROI for corporate marketers.

About Stagwell

Stagwell is the challenger holding company built to transform marketing. We deliver scaled creative performance for the world's most ambitious brands, connecting culture-moving creativity with leading-edge technology to harmonize the art and science of marketing. Led by entrepreneurs, our specialists in 45+ countries are unified under a single purpose: to drive effectiveness and improve business results for our clients. Join us at www.stagwellglobal.com.

For media questions:
Stagwell
pr@stagwellglobal.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

STAGWELL (STGW) REVEALS NEW SINGAPORE HUB TO POWER AI-DRIVEN GROWTH AND INNOVATION ACROSS APAC

STAGWELL (STGW) REVEALS NEW SINGAPORE HUB TO POWER AI-DRIVEN GROWTH AND INNOVATION ACROSS APAC

CARDIFF-BY-THE-SEA, Calif., Jan. 12, 2026 /PRNewswire/ -- Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation (PFA) platform designed to support both ventricular tachycardia (VT) and atrial fibrillation (AF) ablation, today announced that its founder, Steven Mickelsen, MD, will present at the 44th annual J.P. Morgan Healthcare Conference on Thursday, Jan. 15, 2026, at 10 a.m. PT at The Westin St. Francis in San Francisco.

The presentation will feature a company overview, including the FieldForce™ PFA platform, clinical progress in VT, the Field-PULSE AF study, and plans for the upcoming pivotal VT trial.

Field Medical's leadership team will be available for meetings during the conference. To request a meeting, please email ir@fieldmedicalinc.com.

About Field Medical® Inc.
Founded in 2022, Field Medical is a clinical-stage medical technology company committed to advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias. Its FieldForce™ Ablation System integrates a focal catheter design with proprietary FieldBending™ energy designed to safely deliver efficient, precise ablation with the goal of improving outcomes in ventricular and atrial arrhythmia treatment. In 2024, Field Medical earned Breakthrough Device Designation and gained entry into the FDA TAP Pilot Program for its ventricular tachycardia indication. In October 2025, the VCAS trial was published in Circulation.

For more information, visit www.fieldmedicalinc.com and follow us on LinkedIn, X and YouTube.

The FieldForce™ Ablation System is an investigational device and is limited by federal (or U.S.) law to investigational use.

Contacts
Media
Holly Windler
619.929.1275
media@fieldmedicalinc.com

Investor Relations
ir@fieldmedicalinc.com

 

CARDIFF-BY-THE-SEA, Calif., Jan. 12, 2026 /PRNewswire/ -- Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation (PFA) platform designed to support both ventricular tachycardia (VT) and atrial fibrillation (AF) ablation, today announced that its founder, Steven Mickelsen, MD, will present at the 44th annual J.P. Morgan Healthcare Conference on Thursday, Jan. 15, 2026, at 10 a.m. PT at The Westin St. Francis in San Francisco.

The presentation will feature a company overview, including the FieldForce™ PFA platform, clinical progress in VT, the Field-PULSE AF study, and plans for the upcoming pivotal VT trial.

Field Medical's leadership team will be available for meetings during the conference. To request a meeting, please email ir@fieldmedicalinc.com.

About Field Medical® Inc.
Founded in 2022, Field Medical is a clinical-stage medical technology company committed to advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias. Its FieldForce™ Ablation System integrates a focal catheter design with proprietary FieldBending™ energy designed to safely deliver efficient, precise ablation with the goal of improving outcomes in ventricular and atrial arrhythmia treatment. In 2024, Field Medical earned Breakthrough Device Designation and gained entry into the FDA TAP Pilot Program for its ventricular tachycardia indication. In October 2025, the VCAS trial was published in Circulation.

For more information, visit www.fieldmedicalinc.com and follow us on LinkedIn, X and YouTube.

The FieldForce™ Ablation System is an investigational device and is limited by federal (or U.S.) law to investigational use.

Contacts
Media
Holly Windler
619.929.1275
media@fieldmedicalinc.com

Investor Relations
ir@fieldmedicalinc.com

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Field Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Field Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Recommended Articles